{
  "id": "cluster_17_doc2",
  "content": "Advisory memo from Blue Monarch's molecular diagnostics committee: New coverage guidelines for multi-gene panels effective March 2024 require documented family history in first-degree relatives or positive variant in maternal lineage. Windrose Genomics added as Tier 2 provider with specific CPT codes requiring pre-authorization. Claims processed after 3/1/2024 must include pedigree chart and previous single-gene test results if available.",
  "metadata": {
    "format": "insurance_memo"
  }
}